Imipenem And Cilastatin Injection, Powder, For Solution
Product Images NDC 44567-705

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imipenem And Cilastatin (NDC 44567-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of Imipenem, part of the Imipenem and Cilastatin active ingredients, showing the molecular arrangement including hydroxyl, methyl, carboxyl, and thiol side groups, as well as a water molecule (H2O) associated with the compound.*

FDA Label Image

Chemical Structure (Image 02)

Chemical structure diagram of the active ingredients Imipenem and Cilastatin, showing molecular bonds, functional groups, and stereochemistry as depicted in the image.*

FDA Label Image

Imipenem And Cilastatin For Injection 500 mg/500 mg Vial (Image 03)

Label for Imipenem and Cilastatin injection, powder for solution, 500 mg/500 mg per vial. The label indicates it is for intravenous use only, single-dose vial not for direct infusion, and is manufactured by WG Critical Care, LLC. Contains dosage and storage information, barcodes, and regulatory warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.